Home / NIH / Biological Product (except Diagnostic) Manufacturing / Notice

iPSC Culture and Differentiation

Updated

Presolicitation from the National Institutes of Health, for work in Bethesda, Maryland. Due Nov 12, 2026, 9:00 AM (UTC-5), 8 days left.

Be among the first to see new Biological Product Manufacturing contracts
Only new notices that match, once a day.
Solicitation number75N98027Q00053
AgencyNational Institutes of Health
OfficeNational Institutes of Health Olao
Notice typePresolicitation
Set-asideNone
Trade (NAICS)Biological Product (except Diagnostic) Manufacturing (325414)
Product or service codeQ301
Place of performanceBethesda, Maryland
PostedNov 3, 2026
Response deadlineNov 12, 2026, 9:00 AM (UTC-5) (8 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Federal prevailing wage rates for this place: Maryland Davis-Bacon and SCA wage determinations.

Description

Notice of intent – sole-source acquisition Notice No.: The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us.

Description of the Requirement The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years. This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult. To sequence this locus using Nanopore Sequencing technology.

To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide. Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements.

The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement.

Capability statements must be submitted electronically to [email protected] no later than 9:00 a.m. EDT on November 13, 2026. Please reference Notice No. 75N98027Q00053 in the subject line of the submission.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 325414, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for biological product manufacturing work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The National Institutes of Health awarded $5.9 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.

Similar open biological product manufacturing bids

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Animal and Plant Health Inspection Service
Due Nov 10, 2026, 5:00 PM (UTC-6) · 6 days left
Solicitation · Ames, IA · Posted Oct 27, 2026